dentalcorp (TSE:DNTL) Trading 31.8% Higher - Here's Why

Key Points

• dentalcorp Holdings Ltd. saw its share price surge by 31.8%, reaching C$10.91 during mid-day trading, with a significant increase in trading volume.
• The company declared a quarterly dividend of $0.025, set to be paid on October 21st, representing an annualized yield of 0.9%.
• dentalcorp specializes in acquiring dental practices and providing healthcare services across Canada, indicating a focus on the dental services sector.

dentalcorp Holdings Ltd. (TSE:DNTL - )'s share price traded up 31.8% during mid-day trading on Saturday . The company traded as high as C$10.95 and last traded at C$10.91. 6,520,779 shares were traded during mid-day trading, an increase of 3,267% from the average session volume of 193,674 shares. The stock had previously closed at C$8.28.

dentalcorp Trading Up 31.8%

The company has a market cap of C$2.17 billion, a P/E ratio of -47.43, a PEG ratio of -2.69 and a beta of 1.38. The stock's 50 day moving average is C$8.20 and its 200-day moving average is C$8.22. The company has a current ratio of 1.19, a quick ratio of 1.04 and a debt-to-equity ratio of 78.72.

dentalcorp Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, October 21st. Investors of record on Thursday, October 2nd will be paid a $0.025 dividend. This represents a $0.10 dividend on an annualized basis and a yield of 0.9%. dentalcorp's payout ratio is -21.74%.

About dentalcorp

Dentalcorp Holdings Ltd is engaged in acquiring dental practices and providing health care services in Canada. It recognizes revenue for the provision of dental services that are rendered to patients by Partner dentists and dental practitioners contracted by the Professional Corporations and health care services rendered by employees or contractors of the company.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.